Skip to main content
. 2020 Dec 28;57(1):15. doi: 10.3390/medicina57010015

Table 1.

Demographic and clinical data of the study population. CKD, chronic kidney disease; CAKUT, congenital anomalies of kidney and urinary tract; HUS, hemolytic uremic syndrome; HD, hemodialysis; PD, peritoneal dialysis; CKD-MBD, chronic kidney disease—mineral and bone disorder.

All Patients (n = 73)
Age (year) 7.5 (4.0–11.0)
Female/male 35 (47.9)/38 (52.1)
CKD cause
CAKUT 51 (69.9)
Glomerular diseases 13 (17.8)
Nephrolithiasis and nephrocalcinosis 4 (5.5)
HUS 3 (4.1)
Cystic kidney diseases 2 (2.7)
CKD stage
Stage 1 14 (19.2)
Stage 2 15 (20.5)
Stage 3 13 (17.8)
Stage 4 14 (19.2)
Stage 5 17 (23.3)
HD 8 (11)
PD 9 (12.3)
Growth and development
Normal 52 (71.2)
Delay 21(28.8)
CKD-MBD 27 (37)
Renal anemia 25 (34.2)

Data are presented as median (interquartile range (IQR)) or n (%).